Exercise Intolerance and Low Cardiac Filling Pressures in a Woman With a Novel eNOS Mutation

2024-9-27

Polygenic Risk in Families With Dilated Cardiomyopathy

2024-9-26

Polygenic Scoring for Detection of Ascending Thoracic Aortic Dilation

2024-9-26

Role of Calmodulin in Cardiac Disease: Insights on Genotype and Phenotype

2024-9-9

Circulating Blood Plasma Profiling Reveals Proteomic Signature and a Causal Role for SVEP1 in Sudden Cardiac Death

2024-9-5

Clinical Utility of Protein Language Models in Resolution of Variants of Uncertain Significance in <i>KCNQ1, KCNH2</i> , and <i>SCN5A</i> Compared With Patch-Clamp Functional Characterization

2024-8-9

Proteome- and Transcriptome-Wide Genetic Analysis Identifies Biological Pathways and Candidate Drug Targets for Preeclampsia

2024-8-9

Polygenic Risk and Coronary Artery Disease Severity

2024-8-8

How Normal Is Low-Normal Left Ventricular Ejection Fraction in Familial Dilated Cardiomyopathy?

2024-8-8

Loss of Function Variant in <i>SMAD6</i> Is Associated With a Novel Phenotype of Internal Carotid Artery Dissection

2024-7-29

High-Risk Nonclassical Long-QT Syndrome Genotypes: Spectrum of Genetic and Phenotypic Features

2024-7-29

Prediction of Positive Genetic Testing for Arrhythmogenic Left Ventricular Cardiomyopathy

2024-7-29

Multisite Validation of a Functional Assay to Adjudicate <i>SCN5A</i> Brugada Syndrome–Associated Variants

2024-7-2

Rare Variant in <i>MRC2</i> Associated With Familial Supraventricular Tachycardia and Wolff-Parkinson-White Syndrome

2024-7-2

Admixture Mapping of Chronic Kidney Disease and Risk Factors in Hispanic/Latino Individuals From Central America Country of Origin

2024-7-1

Circulating Metabolite Profiles and Risk of Coronary Heart Disease Among Racially and Geographically Diverse Populations

2024-7-1

Invasive Assessment of Coronary Artery Disease in Clonal Hematopoiesis of Indeterminate Potential

2024-6-28

Rapidly Progressive Peripheral Artery Disease: Importance of Oligogenic Inheritance and Functional Validation

2024-6-25

Differential Deep RNA Sequencing for Diagnostic Detection of Microbial Infections in Inflammatory Cardiomyopathy

2024-6-24

Phenotypic Spectrum of Subclinical Sarcomere-Related Hypertrophic Cardiomyopathy and Transition to Overt Disease

2024-6-24

Novel Multiplexed Plasma Biomarker Panel Has Diagnostic and Prognostic Potential in Children With Hypertrophic Cardiomyopathy

2024-6-1

Integrating Clinical Phenotype With Multiomics Analyses of Human Cardiac Tissue Unveils Divergent Metabolic Remodeling in Genotype-Positive and Genotype-Negative Patients With Hypertrophic Cardiomyopathy

2024-6-1

Immune Cellular Dynamics in the Peripheral Blood: A Barometer for Cardiovascular Risk?

2024-6-1

Meta-Analysis of Genome-Wide Association Studies Reveals Genetic Mechanisms of Supraventricular Arrhythmias

2024-5-28

Data Interoperability for Ambulatory Monitoring of Cardiovascular Disease: A Scientific Statement From the American Heart Association

2024-5-23

Using Omics to Identify Novel Therapeutic Targets in Heart Failure

2024-5-20

Single-Cell Dissection of the Immune Response After Acute Myocardial Infarction

2024-5-16

Empagliflozin Attenuates Arrhythmias in an iPSC-Based Model of Hypertrophy Cardiomyopathy

2024-5-16

Heritability of Atrial Fibrillation Among Swedish Adoptees

2024-5-2

Brugada Syndrome in a Transplanted Heart: Implications for Organ Transplant Screening Process

2024-4-23

Vascular Ehlers-Danlos Syndrome: A Comprehensive Natural History Study in a Dutch National Cohort of 142 Patients

2024-4-16

Enhancing the Prediction Power of Polygenic Risk Scores in Genetically Diverse Coronary Heart Disease

2024-4-8

Development and Implementation of an Integrated Preclinical Atherosclerosis Database

2024-4-1

Clinical Guideline for Preimplantation Genetic Testing in Inherited Cardiac Diseases

2024-3-22

Incremental Value of a Metabolic Risk Score for Heart Failure Mortality: A Population-Based Study

2024-3-22

Regional Variation in Cardiovascular Genes Enables a Tractable Genome Editing Strategy

2024-3-20

Reproductive Carrier Screening: Identifying Families at Risk for Familial Hypercholesterolemia in the United States

2024-3-20

Transcription Factors Leave Their Mark on the Heart

2024-3-18

Pooled Genetic Screenings to Identify Likely Pathogenic Variants in Hypertrophic Cardiomyopathy

2024-3-18

Imagenetics for Precision Medicine in Dilated Cardiomyopathy

2024-2-28

Multi-Ancestry Polygenic Risk Score for Coronary Heart Disease Based on an Ancestrally Diverse Genome-Wide Association Study and Population-Specific Optimization

2024-2-21

Resource of Gene Expression Data From a Multiethnic Population Cohort of Induced Pluripotent Stem Cell–Derived Cardiomyocytes

2024-2-19

Dilated Cardiomyopathy With Concomitant Salt-Losing Renal Tubulopathy Caused by Heterozygous <i>RRAGD</i> Gene Variant

2024-2-19

Sex Differences in the Association of Multiethnic Genome-Wide Blood Pressure Polygenic Risk Score With Population-Level Systolic Blood Pressure Trajectories

2024-2-19

Multiplexed Functional Assessments of <i>MYH7</i> Variants in Human Cardiomyocytes

2024-2-16

Role of Genetic Testing for Cardiomyopathies in Pediatric Patients With Left Ventricular Dysfunction Secondary to Chemotherapy

2024-2-15

CYB5R3 T117S Genetic Mutation Is Associated With Major Adverse Cardiovascular and Cerebrovascular Events in Black Adults

2024-2-14

Role of <i>TBX20</i> Truncating Variants in Dilated Cardiomyopathy and Left Ventricular Noncompaction

2024-2-14

DNA Methylation-Based Biomarkers of Protein Levels and Cardiovascular Disease Risk: Opportunities and Challenges for Precision Cardiology

2024-2-13

Crossing the Threshold of Therapeutic Hope for Patients With PKP2 Arrhythmogenic Cardiomyopathy

2024-2-8